Lymphocyte Reconstitution Patterns in People with MS Being Treated with Rituximab After Alemtuzumab to Reduce the Frequency of Autoimmune Adverse Events in the RAMBLE Trial (P12-1.001)
To elucidate the effect of the B-cell agent rituximab on lymphocyte subsets following alemtuzumab therapy in multiple sclerosis (MS).
Authors
- Sofia Jimenez Sanchez
- Simon Broadley (ORCID: https://orcid.org/0000-0002-9429-4307)
- Sonya Marshall‐Gradisnik (ORCID: https://orcid.org/0000-0001-9270-2437)
- Natalie Eaton-Fitch (ORCID: https://orcid.org/0000-0002-0815-3162)
Institutions
- Griffith University (AU)
- Gold Coast Hospital (AU)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211626
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00